Reprint

Molecular Genetics and Pathogenesis of Ehlers–Danlos Syndrome and Related Connective Tissue Disorders

Edited by
July 2020
218 pages
  • ISBN978-3-03936-322-3 (Hardback)
  • ISBN978-3-03936-323-0 (PDF)

This book is a reprint of the Special Issue Molecular Genetics and Pathogenesis of Ehlers–Danlos Syndrome and Related Connective Tissue Disorders that was published in

Biology & Life Sciences
Summary

Ehlers–Danlos syndromes (EDS) are a group of heritable connective tissue disorders (HCTDs) characterized by a variable degree of skin hyperextensibility, joint hypermobility and tissue fragility. The current EDS classification distinguishes 13 subtypes and 19 different causal genes mainly involved in collagen and extracellular matrix synthesis and maintenance. EDS need to be differentiated from other HCTDs with a variable clinical overlap, including Marfan syndrome and related disorders, some types of skeletal dysplasia and cutis laxa. The clinical recognition of EDS is not always straightforward, and, for a definite diagnosis, molecular testing can be of great assistance, especially in patients with an uncertain phenotype. Currently, the major challenging task in EDS is to unravel the molecular basis of the hypermobile EDS that is the most frequent form, and for which the diagnosis is only clinical in the absence of any definite laboratory test. This EDS subtype, as well as other EDS-reminiscent phenotypes, are currently investigated worldwide to unravel the primary genetic defect and related pathomechanisms. The research articles, case report, and reviews published in the Special Issue entitled “Molecular Genetics and Pathogenesis of Ehlers–Danlos Syndrome and Related Connective Tissue Disorders” focus on different clinical, genetic and molecular aspects of several EDS subtypes and some related disorders, offering novel findings and future research and nosological perspectives.

Format
  • Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
classical Ehlers-Danlos syndrome; classical-like Ehlers-Danlos syndrome type 2; AEBP1; aortic carboxypeptidase-like protein; differential diagnosis; high-frequency ultrasonography; reflectance confocal microscopy; fibrillin 1; Marfan syndrome; MASS syndrome; mRNA; splicing; kyphoscoliotic Ehlers–Danlos Syndrome; EDS type VI; transcriptomics; connective tissue; extracellular matrix; PLOD1; FKBP14; occipital horn syndrome; Ehlers–Danlos syndrome type IX; Menkes syndrome; ATP7A; review; copper transport; elastic fiber; collagen; autophagy; collagen III; collagen V; Ehlers‒Danlos syndrome; endoplasmic reticulum; extracellular matrix; fibroblast-to-myofibroblast transition; miRNA; transcriptome; wound healing; linkeropathies; B3GAT3; Larsen-like syndrome; B4GALT7; B3GALT6; spondylodysplastic Ehlers-Danlos syndrome; XYLT1; XYLT2; Desbuquois dysplasia; spondylo-ocular syndrome; classical Ehlers-Danlos Syndrome; electron microscopy; collagen flowers; COL5A1; hereditary connective tissue disorders; Loeys-Dietz syndrome; Ehlers-Danlos syndrome; arterial aneurysms; TGFBR1; TGFBR2; SMAD2; SMAD3; TGFB2; TGFB3.; beta-1,3-galactosyltransferase 6 (B3GALT6); beta-1,4-galactosyltransferase 7 (B4GALT7); spondyloepimetaphyseal dysplasia with joint laxity (SEMDJL1; SEMDJL-Beighton type); Ehlers–Danlos syndrome (EDS); spondylodysplastic Ehlers–Danlos syndrome (spEDS); spEDS-B3GALT6; spEDS-B4GALT7; extreme laxity of distal joints; soft; doughy skin on the hands and feet; Tenascin X; TNXB; Ehlers-Danlos syndrome; EDS; connective tissue; collagen; Classical-like; Ehlers-Danlos syndrome; haploinsufficiency; tenascin-X; TNXB; musculocontractural Ehlers–Danlos Syndome; carbohydrate sulfotransferase-14 (CHST14)/dermatan 4-O-sulfotransferase-1 (D4ST1); CHST14; dermatan sulfate epimerase (DSE); DSE; dermatan sulfate (DS); decorin; collagen; Ehlers-Danlos syndromes; pulse wave velocity; blood pressure; orthostatic intolerance; Ehlers–Danlos syndrome; SLC39A13; dysmorphology; short stature; connective tissue; DeepGestalt technology; Ehlers–Danlos syndrome; heritable connective tissue disorders; differential diagnosis; next generation sequencing (NGS); transcriptomics; integrated omics approaches